America First Investment Advisors LLC decreased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 3.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,161 shares of the financial services provider’s stock after selling 2,997 shares during the period. CME Group makes up 5.2% of America First Investment Advisors LLC’s holdings, making the stock its 8th biggest holding. America First Investment Advisors LLC’s holdings in CME Group were worth $26,228,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Webster Bank N. A. lifted its stake in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC grew its stake in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Trifecta Capital Advisors LLC increased its holdings in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares in the last quarter. Ransom Advisory Ltd acquired a new position in CME Group in the first quarter valued at approximately $31,000. Finally, Westside Investment Management Inc. lifted its stake in CME Group by 105.0% in the second quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after buying an additional 63 shares during the period. Institutional investors own 87.75% of the company’s stock.
Insider Buying and Selling at CME Group
In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares of the company’s stock, valued at $287,511.23. This trade represents a 47.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 14,043 shares of company stock valued at $3,791,486 in the last ninety days. 0.30% of the stock is owned by corporate insiders.
CME Group Stock Up 0.1%
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business posted $2.68 EPS. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on CME. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. UBS Group cut their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Barclays dropped their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Finally, Piper Sandler increased their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $287.65.
Get Our Latest Analysis on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Stock Splits, Do They Really Impact Investors?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to Evaluate a Stock Before Buying
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
